200 related articles for article (PubMed ID: 34392914)
21. PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma.
Seval GC; Ozkan E; Beksac M
PET Clin; 2019 Jul; 14(3):369-381. PubMed ID: 31084776
[TBL] [Abstract][Full Text] [Related]
22. The Utility of 18F-fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Cutaneous B-Cell Lymphoma.
Feuerman H; Snast I; Amitay-Laish I; Bairey O; Barzilai A; Feinmesser M; Mimouni D; Even-Sapir E; Hodak E
Isr Med Assoc J; 2019 Sep; 21(9):580-584. PubMed ID: 31542900
[TBL] [Abstract][Full Text] [Related]
23. FDG PET Hybrid Imaging.
Becker J; Schwarzenböck SM; Krause BJ
Recent Results Cancer Res; 2020; 216():625-667. PubMed ID: 32594401
[TBL] [Abstract][Full Text] [Related]
24. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
Kitajima K; Doi H; Kuribayashi K
Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
[TBL] [Abstract][Full Text] [Related]
25. Whole body MRI and PET/CT in haematological malignancies.
Lin C; Luciani A; Itti E; Haioun C; Rahmouni A
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S88-93. PubMed ID: 17921084
[TBL] [Abstract][Full Text] [Related]
26. PET Imaging for Gynecologic Malignancies.
Friedman SN; Itani M; Dehdashti F
Radiol Clin North Am; 2021 Sep; 59(5):813-833. PubMed ID: 34392921
[TBL] [Abstract][Full Text] [Related]
27. Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies.
Behzadi AH; Raza SI; Carrino JA; Kosmas C; Gholamrezanezhad A; Basques K; Matcuk GR; Patel J; Jadvar H
PET Clin; 2018 Oct; 13(4):623-634. PubMed ID: 30219192
[TBL] [Abstract][Full Text] [Related]
28. [Metabolic imaging in lymphoid hemopathies].
Itti E
Rev Prat; 2021 May; 71(5):540-542. PubMed ID: 34553535
[TBL] [Abstract][Full Text] [Related]
29. Role of positron emission tomography/computed tomography in bone malignancies.
Peller PJ
Radiol Clin North Am; 2013 Sep; 51(5):845-64. PubMed ID: 24010909
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous lesions of a blastic plasmacytoid dendritic cell neoplasm.
Suemori K; Fujiwara H; Niiya T; Yasukawa M
Intern Med; 2014; 53(4):339-40. PubMed ID: 24531095
[No Abstract] [Full Text] [Related]
31. Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders.
Ulaner GA; Landgren CO
Best Pract Res Clin Haematol; 2020 Mar; 33(1):101148. PubMed ID: 32139013
[TBL] [Abstract][Full Text] [Related]
32. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
[TBL] [Abstract][Full Text] [Related]
34. Precision Medicine and PET-Computed Tomography in Pediatric Malignancies.
Sanli Y; Yilmaz E; Subramaniam RM
PET Clin; 2017 Oct; 12(4):423-435. PubMed ID: 28867113
[TBL] [Abstract][Full Text] [Related]
35. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H
Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800
[TBL] [Abstract][Full Text] [Related]
36. Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma.
Qi Z; Gates EL; O'Brien MM; Trout AT
Pediatr Radiol; 2018 Feb; 48(2):196-203. PubMed ID: 29080987
[TBL] [Abstract][Full Text] [Related]
37. [Hybrid imaging in lymphoma].
Mayerhöfer ME; Haug A
Radiologe; 2020 May; 60(5):376-385. PubMed ID: 32296856
[TBL] [Abstract][Full Text] [Related]
38. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
39. Challenges in Interpretation of Staging PET/CT in Thoracic Malignancies.
Shroff GS; Carter BW; Viswanathan C; Benveniste MF; Wu CC; Marom EM; Mawlawi OR; Truong MT
Curr Probl Diagn Radiol; 2017; 46(4):330-341. PubMed ID: 28159371
[No Abstract] [Full Text] [Related]
40. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
